MassBio CEO & President Kendalle Burlin O’Connell originally posted this update to LinkedIn: This week, MassBio hosted our 2026 Align Summit, where policy and regulatory leaders joined industry ...
Global law firm Greenberg Traurig, LLP sponsored Kisaco Research’s IP Litigation North America Summit Sept. 14-16. The inaugural event brought together three dedicated industry tracks under one roof, ...
Global law firm Greenberg Traurig, LLP hosted its inaugural Emerging Tech Summit – East Sept. 23 in Boston. The summit brought together investors, founders, financial institutions, and legal leaders ...
MassBio CEO & President Kendalle Burlin O’Connell originally posted this to LinkedIn: “Undruggable.” For decades, that’s what ...
Colleagues, I’m writing to let you know about FDA’s new Expedited IND Pilot Program and to ask for your help making sure ...
Exciting news! Diaceutics have launched Precision for All, our evolution to unlock the potential of over 700 therapies and improve even more patients lives. Between scientific innovation and real life ...
MassBio CEO & President Kendalle Burlin O’Connell originally shared this update on LinkedIn: I’ve been to plenty of ribbon cuttings in this job, but rarely three in one week, and rarely three that ...
Chinh H. Pham, co-chair of the Venture Capital & Emerging Technology Group of global law firm Greenberg Traurig, LLP, participated in the panel discussion “Breaking into the Boardroom,” co-hosted by ...
The fifth edition of o2h Technology’s Tech Kickstarter Competition has been launched. The contest has been helping seed and early-stage companies to accelerate their digital progress by transforming ...
Join MassBio for the 2026 Patient Advocacy Summit on Thursday, November 12, in the MassBioHub. This event showcases the work patient advocates do every day to ensure that patients are front and center ...
Results from RAPIDe-3 demonstrate that treatment with deucrictibant IR resulted in faster time to onset of symptom relief (1.28 hours) and to complete symptom resolution (11.95 hours) Deucrictibant IR ...
Cell line development is a critical step in establishing a robust foundation for biologics manufacturing. In our latest on-demand Expert Insights video, Sebastian Schwamb, our Senior Director Process ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results